Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Rangering i aksjer #18714
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Aksjekurs
$2.49
Markedsverdi
$4.47M
Endring (1 dag)
-4.01%
Endring (1 år)
678.16%
Land
MY
Handel BioNexus Gene Lab Corporation (BGLC)

Kategori

P/B-forhold for BioNexus Gene Lab Corporation (BGLC)
P/B-forhold per March 2026 TTM: 0.59
Ifølge BioNexus Gene Lab Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0.59. Ved slutten av 2023 hadde selskapet et P/B-forhold på 0.95.
P/B-historikk for BioNexus Gene Lab Corporation fra 2016 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
2026 (TTM) 0.59 -1.60%
2024 0.60 -36.56%
2023 0.95 -96.17%
2022 24.65 -51.50%
2021 50.81 49.46%
2020 34.00 -79.93%
2019 169.36 76.55%
2018 95.93 -94.47%
2017 1.74K -101.39%
2016 -125.28K 0.00%
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
3.2693 453.74%
US
2.522 327.17%
US
28.6291 4,749.10%
US
3.6303 514.89%
CN
4.5682 673.75%
US